In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Abbott India has informed that Anuj Mehra, Senior Management Personnel (SMP), has been designated as Commercial Director - NeuroLife, GenNext and Vaccines effective February 1, 2025. The additional details required under the SEBI Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 is enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.
